The Interministerial Medicinal Product Pricing Committee (CIPM) continues to increase the transparency of its decisions

//The Interministerial Medicinal Product Pricing Committee (CIPM) continues to increase the transparency of its decisions

The Interministerial Medicinal Product Pricing Committee (CIPM) continues to increase the transparency of its decisions

The Interministerial Medicinal Product Pricing Committee (CIPM) continues to increase the transparency of its decisions: novelties in the P&R agreements in Spain. The Spanish Ministry of Health is spreading public information on pricing agreements and financing conditions.

Click the following link to download the translated news: The Spanish MoH expands public information on pricing agreements and reimbursement conditions

2019-07-04T19:43:55+00:00July 4th, 2019|News|

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies